Trial of a ground-breaking nuclear medicine treatment for men with advanced prostate cancer is open

30 January 2018

In July 2017, ANZUP Cancer Trials Group Limited (ANZUP) and Prostate Cancer Foundation of Australia (PCFA) launched the first Australian trial of a ground-breaking nuclear medicine treatment for men with advanced prostate cancer.

We are pleased to announce that this trial was opened at Peter MacCallum Cancer Centre in Melbourne yesterday on Monday 29^th January 2018, with the additional sites to open in the following months. Please click here to find out more: https://clinicaltrials.gov/show/NCT03392428

For further details and advice regarding eligibility, please get in touch with your treating physician.

A list of Frequently Asked Questions with answers about the Lutetium-PSMA (Lu-PSMA) prostate cancer trial is available here http://www.anzup.org.au/content.aspx?page=lutetiumprostatecancertrial.